Melanoma Clinical Trials
In active follow-up
SLNB: The Sentinel Lymph Node Biopsy study is a randomised, feasibility study investigating the diagnosis and treatment of early lymph node involvement in patients with primary cutaneous melanoma by sentinel lymph node biopsy with or without completion lymphadenectomy and molecular markers.
MSG/BAPS: MSG/BAPS randomised trial of width of excision of thick cutaneous malignant melanoma.
NICAM: A Phase II Trial of Nilotinib in the treatment of patients with c-KIT mutated advanced acral and mucosal melanoma. NICAM is a single arm Phase II trial for patients with advanced c-KIT mutated acral or mucosal melanoma.